Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocraft Laboratories Inc
Original Assignee
Biocraft Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocraft Laboratories IncfiledCriticalBiocraft Laboratories Inc
Priority to ES453036ApriorityCriticalpatent/ES453036A1/es
Publication of ES453036A1publicationCriticalpatent/ES453036A1/es
Un procedimiento para obtener compuestos de 2'-o-acil-, 3'-o-acil-, 2',3'-di-o-acil- y 2',3',5'-tri-o-acil-2-b-d-ribofuranosilselenazol-4-carboxamida
Un procedimiento nuevo de transformacion de cefalotina sodi-ca en hidrotiocianato 7-(2-tienilacetamida)-3-(1-piridilme- til) 3-cefen-4-4carboxilico betaina acida.